Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ontak in Advanced Refractory Breast Cancer
NCT00425672Phase 2Completed
- Sponsor
- University of Washington
- Start
- Sep 2005
- Primary completion
- Apr 2010
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of denileukin diftitox in breast cancer, sponsored by University of Washington. Started Sep 2005; status: completed.
02
Drugs
denileukin diftitox
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00425672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425672.